Alzheimer's Drug Discovery Research

This is a London news story, published by MSN, that relates primarily to Prof Fiona Ducotterd news.

London news

For more London news, you can click here:

more London news

Prof Fiona Ducotterd news

For more Prof Fiona Ducotterd news, you can click here:

more Prof Fiona Ducotterd news

drug discoveries news

For more drug discoveries news, you can click here:

more drug discoveries news

MSN news

For more news from MSN, you can click here:

more news from MSN

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about

patients

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Alzheimer news, dementia research news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

medicine

Telegraph

•

Inside Britain’s groundbreaking Alzheimer’s drug lab where scientists are racing to find a cure

Summary

Nutrition label

79% Informative

Prof Fiona Ducotterd is the chief scientific officer of Alzheimer's Research UK's Drug Discovery Institute (DDI) She was drawn back to the lab in London by the unique combination of factors offered by the DDI.

The DDI is helping to streamline the process of creating new drugs.

The success of lecanab, a drug that has been shown to slow Alzheimer’s progression by 30 per cent in early-stage patients, has energised the field by showing progress is possible rather than possible.

One of the projects Ducotterd is particularly excited about leveraging human genetics to mimic natural resilience against dementia.

She is also keen that their treatments are not too invasive for the patient.

One in two of us will be affected by dementia if we don't develop treatments, she says.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language